Accordingly, a previous study by Wu et al. demonstrated an abemaciclib-induced increase in intracellular accumulation of doxorubicin and rhodamine 123, both substrates of ABCB1 and ABCG2, in transporter-overexpressing cancer cells [27]. Here, ABCB1 is linked to cancer.